507 related articles for article (PubMed ID: 21216540)
41. Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.
Fraile L; Grau-Roma L; Sarasola P; Sinovas N; Nofrarías M; López-Jimenez R; López-Soria S; Sibila M; Segalés J
Vaccine; 2012 Mar; 30(11):1986-92. PubMed ID: 22245604
[TBL] [Abstract][Full Text] [Related]
42. A comparative efficacy test of 1
Do DT; Tran KDV; Quach AT; Lee D; Chang FC; Wu CP; Tat TN; Chae C
Can J Vet Res; 2021 Apr; 85(2):93-100. PubMed ID: 33883815
[TBL] [Abstract][Full Text] [Related]
43. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
[TBL] [Abstract][Full Text] [Related]
44. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
Kixmöller M; Ritzmann M; Eddicks M; Saalmüller A; Elbers K; Fachinger V
Vaccine; 2008 Jun; 26(27-28):3443-51. PubMed ID: 18513842
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions.
Seo HW; Han K; Oh Y; Park C; Chae C
Vaccine; 2012 Oct; 30(47):6671-7. PubMed ID: 22963801
[TBL] [Abstract][Full Text] [Related]
46. Can Porcine circovirus type 2 (PCV2) infection be eradicated by mass vaccination?
Feng H; Blanco G; Segalés J; Sibila M
Vet Microbiol; 2014 Aug; 172(1-2):92-9. PubMed ID: 24906871
[TBL] [Abstract][Full Text] [Related]
47. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
Alberti KA; Estienne MJ; Meng XJ
J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
[TBL] [Abstract][Full Text] [Related]
48. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
Wang X; Jiang P; Li Y; Jiang W; Dong X
Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
[TBL] [Abstract][Full Text] [Related]
49. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
Li PC; Qiao XW; Zheng QS; Hou JB
Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
[TBL] [Abstract][Full Text] [Related]
50. Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload.
Guarneri F; Tresoldi ET; Sarli G; Boniotti MB; Lelli D; Barbieri I; Bacci B; D'Annunzio G; Amadori M
Vet Microbiol; 2021 Jan; 252():108887. PubMed ID: 33276254
[TBL] [Abstract][Full Text] [Related]
51. Effect of porcine circovirus type 2 (PCV2) load in serum on average daily weight gain during the postweaning period.
López-Soria S; Sibila M; Nofrarías M; Calsamiglia M; Manzanilla EG; Ramírez-Mendoza H; Mínguez A; Serrano JM; Marín O; Joisel F; Charreyre C; Segalés J
Vet Microbiol; 2014 Dec; 174(3-4):296-301. PubMed ID: 25448444
[TBL] [Abstract][Full Text] [Related]
52. Efficacy in pigs of a new inactivated vaccine combining porcine circovirus type 2 and Mycoplasma hyorhinis.
Wei YW; Zhu HZ; Huang LP; Xia DL; Wu HL; Bian HQ; Feng L; Liu CM
Vet Microbiol; 2020 Mar; 242():108588. PubMed ID: 32122592
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
54. Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection.
Yang S; Oh T; Mago J; Iwakuma A; Chae C
Vet Med Sci; 2020 Nov; 6(4):860-874. PubMed ID: 32462794
[TBL] [Abstract][Full Text] [Related]
55. Lack of effect of piglet vaccination against Porcine circovirus type 2 (PCV2) on serum viral loads of Torque teno sus virus 2 (TTSuV2).
Nieto D; Aramouni M; Sibila M; Fraile L; Kekarainen T; Segalés J
Vet Microbiol; 2012 May; 157(1-2):8-12. PubMed ID: 22189433
[TBL] [Abstract][Full Text] [Related]
56. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
[TBL] [Abstract][Full Text] [Related]
57. Virological and serological characterization of vaccinated and non-vaccinated piglet subpopulations coming from vaccinated and non-vaccinated sows.
Fraile L; Segalés J; Ticó G; López-Soria S; Valero O; Nofrarías M; Huerta E; Llorens A; López-Jiménez R; Pérez D; Sibila M
Prev Vet Med; 2015 May; 119(3-4):153-61. PubMed ID: 25748003
[TBL] [Abstract][Full Text] [Related]
58. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
[TBL] [Abstract][Full Text] [Related]
59. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of single dose of an inactivated porcine circovirus type 2 (PCV2) whole-virus vaccine with oil adjuvant in piglets.
Yang K; Li W; Niu H; Yan W; Liu X; Wang Y; Cheng S; Ku X; He Q
Acta Vet Scand; 2012 Nov; 54(1):67. PubMed ID: 23171757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
